UNSPSC 51281703: Ampicillin

This classification denotes a penicillin antibiotic with the molecular formula C16H19N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C782967RD, chemically known as penicillin, (aminophenylmethyl)- but generally known as ampicillin, which bears US NIH Compound Identifier 2174.

UNSPSC 51281703 Ampicillin is a Commodity code that nominally covers a specific antibiotic product, but recent state and local procurement activity under this code shows little direct alignment with ampicillin procurement. The sourced opportunities reference pharmaceutical warehouse piggyback contracts and naloxone procurement — neither of which involves ampicillin — and suggest that agencies tag antibiotic or pharmaceutical-adjacent buys under this code inconsistently. State and local health departments, counties, and emergency management agencies are the primary issuing bodies pursuing pharmaceutical procurement, though the specific products solicited diverge markedly from the code's nominal scope.

Recent activity appears concentrated in Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback pharmaceutical contract to Chartwell Rx LLC in August 2026 through the MMCAP Infuse consortium for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets (IFB notice, completed award). Seminole County, Florida issued an IFB in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida (response deadline July 26, 2023). The code shows limited coherence as a procurement taxonomy signal — firms pursuing pharmaceutical supply contracts with state and local health authorities should monitor MMCAP Infuse and equivalent cooperative purchasing consortia and county health procurement channels rather than relying on consistent UNSPSC tagging under this code.